Cargando…

Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial

AIM: To evaluate the possible role of dosimetric parameters according Normal Tissue Complication Probability (NTCP) model as predictive of late toxicity and cosmesis in hypofractionated whole-breast three-dimensional conformal radiotherapy. PATIENTS AND METHODS: A retrospective analysis on 215 conse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lazzari, Grazia, Terlizzi, Angela, Della Vittoria Scarpati, Giuseppina, Perri, Francesco, De Chiara, Vincenzo, Turi, Barbara, Silvano, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373827/ https://www.ncbi.nlm.nih.gov/pubmed/28392704 http://dx.doi.org/10.2147/OTT.S127833

Ejemplares similares

Oral vinorelbine: a feasible and safe partner for radiotherapy in the treatment of locally advanced non-small cell lung cancer
por: Perri, Francesco, et al.
Publicado: (2016)

Effective nivolumab sequential thoracic radiotherapy in elderly patients with advanced squamous cell lung cancer: did radiation therapy play a role? A case report
por: Lazzari, Grazia, et al.
Publicado: (2018)

Single nucleotide polymorphisms and unacceptable late toxicity in breast cancer adjuvant radiotherapy: a case report
por: Lazzari, Grazia, et al.
Publicado: (2017)

Hypofractionated whole breast radiotherapy: current perspectives
por: Koulis, Theodora A, et al.
Publicado: (2015)

Management of Ewing Sarcoma Family of Tumors: A Short Description of a Rare Primitive Uterine pPNET and Literature Review
por: Pisconti, Salvatore, et al.
Publicado: (2020)

Ultra-Hypofractionated vs. Moderate Fractionated Whole Breast Three Dimensional Conformal Radiotherapy during the COVID-19 Pandemic
por: Ivanov, Olivera, et al.
Publicado: (2022)

Genetics and management of locally advanced carcinomas of the head and neck: role of altered fractionation radiotherapy
por: Perri, Francesco, et al.
Publicado: (2018)

Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
por: Xie, Xue-Yi, et al.
Publicado: (2022)

Ipilimumab in the treatment of metastatic melanoma: management of adverse events
por: Della Vittoria Scarpati, Giuseppina, et al.
Publicado: (2014)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

VMAT radiation-induced nausea and vomiting in adjuvant breast cancer radiotherapy: The incidental effect of low-dose bath exposure
por: Lazzari, G., et al.
Publicado: (2017)

Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen
por: Perri, Francesco, et al.
Publicado: (2015)

Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy
por: Liuzzi, Raffaele, et al.
Publicado: (2020)

Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors
por: Ciammella, Patrizia, et al.
Publicado: (2014)

1-week hypofractionated adjuvant whole-breast radiotherapy: towards a new standard?
por: Levy, Antonin, et al.
Publicado: (2020)

Tumor grade and molecular subtypes on local control in breast cancer radiotherapy: Does fractionation really matter? A retrospective control study group
por: Lazzari, G., et al.
Publicado: (2018)

Review of Hypofractionated Radiotherapy for Prostate Cancer
por: Spyropoulou, Despina, et al.
Publicado: (2012)

The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017)

Cost Minimization Analysis of Hypofractionated Radiotherapy
por: Yaremko, Hannah L., et al.
Publicado: (2021)

Hypofractionated Radiotherapy in African Cancer Centers
por: Swanson, William, et al.
Publicado: (2021)

Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy
por: Perri, Francesco, et al.
Publicado: (2019)

Hypofractionated three-dimensional conformal radiotherapy for medically inoperable early stage non-small-cell lung cancer
por: Lee, Joo Ho, et al.
Publicado: (2013)

Management of HPV-Related Squamous Cell Carcinoma of the Head and Neck: Pitfalls and Caveat
por: Perri, Francesco, et al.
Publicado: (2020)

Translational Insights and New Therapeutic Perspectives in Head and Neck Tumors
por: Fasano, Morena, et al.
Publicado: (2021)

Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
por: Cho, L. Chinsoo, et al.
Publicado: (2013)

Image Fusion for Radiosurgery, Neurosurgery and Hypofractionated Radiotherapy
por: Inoue, Hiroshi K, et al.
Publicado: (2015)

Hypofractionated radiotherapy to treat acne keloidalis nuchae
por: Kwan, Jennifer Yin Yee, et al.
Publicado: (2021)

Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity
por: Deantonio, Letizia, et al.
Publicado: (2010)

Metastatic HPV‐related oropharyngeal carcinoma cured with chemoradiotherapy: importance of pretherapy biomolecular assessment
por: Perri, Francesco, et al.
Publicado: (2017)

Pompe practice survey of Canadian (Ontario) rheumatologists
por: Thorne, Carter, et al.
Publicado: (2013)

Optimal hypofractionated conformal radiotherapy for large brain metastases in patients with high risk factors: a single-institutional prospective study
por: Inoue, Hiroshi K, et al.
Publicado: (2014)

Comment on Ivanov et al. Ultra-Hypofractionated vs. Moderate Fractionated Whole Breast Three Dimensional Conformal Radiotherapy during the COVID-19 Pandemic. Medicina 2022, 58, 745
por: Ferini, Gianluca
Publicado: (2022)

Breast Cancer Adjuvant Radiotherapy in BRCA1/2, TP53, ATM Genes Mutations: Are There Solved Issues?
por: Lazzari, Grazia, et al.
Publicado: (2021)

Hypofractionated Radiotherapy as Local Hemostatic Agent in Advanced Cancer
por: Rasool, Malik Tariq, et al.
Publicado: (2011)

Hypofractionated radiotherapy has the potential for second cancer reduction
por: Schneider, Uwe, et al.
Publicado: (2010)

Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
por: Lewitzki, Victor, et al.
Publicado: (2015)

Hypofractionated ablative radiotherapy for locally advanced pancreatic cancer
por: Crane, Christopher H.
Publicado: (2016)

Automated prediction of dosimetric eligibility for hypofractionated prostate radiotherapy
por: Lausch, Anthony, et al.
Publicado: (2017)

Clinical outcomes of hypofractionated radiotherapy for thyroid-associated ophthalmopathy
por: Lee, Sang Min, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1bjbit61462qu4ngo6vl529e5k